CHRISTINA BARNETT: Open Payments
NPI 1710508049 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 39 payments from 9 companies in 2025. Trend: 2023 $669 · 2024 $620 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 3 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $148 |
| GlaxoSmithKline, LLC. | 12 | $137 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| GENZYME CORPORATION | 2 | $79 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $25 |
Products named: Xolair, DUPIXENT, AIRSUPRA, NUCALA, FASENRA, TRELEGY ELLIPTA, NEFFY, Rhapsido.
Industry payments across VA — which companies pay providers there.
